Anika Therapeutics Inc (NAS:ANIK)
$ 17.35 -0.2 (-1.14%) Market Cap: 254.10 Mil Enterprise Value: 219.27 Mil PE Ratio: 0 PB Ratio: 1.42 GF Score: 70/100

Anika Therapeutics Inc Host its Virtual Investor Day Transcript

Jun 03, 2021 / 01:00PM GMT
Release Date Price: $46.63 (-0.55%)
Mark Namaroff
Anika Therapeutics, Inc. - Executive Director of IR & Corporate Communications

Welcome, everybody. Good morning. Welcome. My name is Mark Namaroff. I'm Head of Investor Relations and Corporate Communications for Anika, and welcome to our 2021 Virtual Investor Day. We have a great event for you planned today. We hope that by the end of today, you'll leave with a better understanding of Anika's strategy, our served markets, our product portfolio, our R&D pipeline and our ability to execute commercially to deliver growth over the coming years.

We actually got together a few months back. We debated whether to have this Investor Day virtually rather than waiting maybe until the fall where we could do this event live. We actually decided that doing it sooner rather than later was better for our investors, our prospective investors and our analysts to give you a better perspective of now Anika after the transformation that we've gone through over the past 18 months or so. Anika is a much different company today than where it was back in 2019, if you remember from our last Investor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot